دراسة انتشار المقاومة للفلوروكينولونات عند الأمعائيات
Abstract
Multidrug resistant (MDR) strains of the Gram-negative pathogenic bacterium, Enterobacteriace, particularly fluoroquinolone-resistant strains, are the major causative agents for hospital acquired (HA) infections, as well as epidemics linked to gastrointestinal (GI), urinary tracts, also pneumonia , abscess, meningitis and sepsis.
The prevalence of fluoroquinolone-resistance among 3107 strains of enterobacteriace, isolated from clinical samples of patients with infections caused by enterobacteriace at Al-Assad and Tichreen University Hospitals, Lattakia, Syria, over 6 years (2011-2016) is recorded, along with sensitivity patterns to currently used anti-biotics, including cephalosporins aminoglycosides, pencellins and fluoroquinolones with disc-diffusion method.
A total of 3107 strains of enterobacteriace were isolated from the clinical samples, 925 strains of them were fluoroquinolone-resistant (30%) , of which 272 isolates were from CA samples (29%) and 653 isolates were from hospitalized patients HA (71%) during the study period. We found a high prevalence of resistance towards the drugs used as “first-line” when treating UTIs: ampicillin, cotrimoxazole, and ciprofloxacin (90%, 96%, and 32% resistance, respectively)
تعتبر الجراثيم سالبة الغرام ذات المقاومة الدوائية المتعددة و خاصةً الأمعائيات المقاومة للفلوروكينولونات من المسببات الرئيسية للإنتانات المكتسبة في المشافي خاصةً الإنتانات المعوية وإنتانات السبيل البولي وغيرها من إنتانات الجروح والتهاب السحايا والالتهاب الرئوي.
شملت هذه الدراسة الراجعة (3107) عينة من عزولات الأمعائيات في قسم الأحياء الدقيقة في مشفيي الأسد وتشرين الجامعيين في اللاذقية بين عامي (2011- 2016). والتي أجري لها اختبار الحساسية للصادات بطريقة الانتشار القرصي مع استخدام واحد أو أكثر من عائلة الفلوروكينولونات (السيبروفلوكساسين والليفوفلوكساسين والنورفلوكساسين)
من بين ال (3107) عزولة جرثومية كان هناك (925) عزولة جرثومية مقاومة للفلوروكينولونات بنسبة (30%). وكان منها (653) عزولة من مرضى مقيمين للاستشفاء في المشفى مقاومة للفلوروكينولونات بنسبة (71%) و(272) عزولة من مرضى خارج المشفى مقاومة للفلوروكينولونات بنسبة(29%). وجدنا نسبة عالية من المقاومة تجاه الصادات التي تعتبر الخط الأول في علاج إنتانات السبيل البولي: الأمبيسيللين , الكوتريموكسازول, السيبروفلوكساسين ( 90% , 96% , 32% عل التوالي ).
Downloads
Published
How to Cite
Issue
Section
License

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
The authors retain the copyright and grant the right to publish in the magazine for the first time with the transfer of the commercial right to Tishreen University Journal for Research and Scientific Studies - Health Sciences Series
Under a CC BY- NC-SA 04 license that allows others to share the work with of the work's authorship and initial publication in this journal. Authors can use a copy of their articles in their scientific activity, and on their scientific websites, provided that the place of publication is indicted in Tishreen University Journal for Research and Scientific Studies - Health Sciences Series . The Readers have the right to send, print and subscribe to the initial version of the article, and the title of Tishreen University Journal for Research and Scientific Studies - Health Sciences Series Publisher
journal uses a CC BY-NC-SA license which mean
You are free to:
- Share — copy and redistribute the material in any medium or format
- Adapt — remix, transform, and build upon the material
- The licensor cannot revoke these freedoms as long as you follow the license terms.
- Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- NonCommercial — You may not use the material for commercial purposes.
- ShareAlike — If you remix, transform, or build upon the material, you must distribute your contributions under the same license as the original.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.